Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
No clinical trials have been registered for primary pulmonary vein stenosis.
5 publications have been identified in PubMed for primary pulmonary vein stenosis. Research spans Case Report / Case Series (40%), Basic Science / Preclinical (40%), and Epidemiology / Natural History (20%).
Nassetta K (2026). [PMID: 41862593](https://pubmed.ncbi.nlm.nih.gov/41862593/). *J Perinatol*. [Case Report / Case Series]
Kim H (2026). [PMID: 41036869](https://pubmed.ncbi.nlm.nih.gov/41036869/). *J Thorac Imaging*. [Case Report / Case Series]
Kalustian AB (2025). [PMID: 40923050](https://pubmed.ncbi.nlm.nih.gov/40923050/). *JTCVS Open*. [Basic Science / Preclinical]
Wang Z (2025). [PMID: 39961772](https://pubmed.ncbi.nlm.nih.gov/39961772/). *Cardiol Young*. [Epidemiology / Natural History]
Devlin C (2024). [PMID: 39026997](https://pubmed.ncbi.nlm.nih.gov/39026997/). *Front Cardiovasc Med*. [Basic Science / Preclinical]
Data assembled from 3 of 12 sources · Last updated Nov 4, 2026, 12:04 PM UTC
European rare disease database
AI-curated news mentioning primary pulmonary vein stenosis
Updated Sep 21, 2026
A new computational framework has been developed to quantify hemodynamic burden in pediatric pulmonary vein stenosis. This advancement could enhance understanding and treatment strategies for this condition.
A case report highlights the potential of immune checkpoint inhibitor rechallenge following pazopanib treatment in a patient with primary pulmonary angiosarcoma. This study contributes to the understanding of treatment strategies for this rare cancer.
Recent research highlights pathological advances and clinical management insights into primary pulmonary myxoid sarcoma associated with the rare EWSR1::CREB1 fusion. This study provides valuable information for understanding this rare tumor's characteristics and potential treatment strategies.